INS and metabolic dysfunction-associated steatohepatitis: Since insulin resistance is nearly universal in the patients with NASH, and it plays a pivotal role in the pathogenesis of NASH, many studies attempted to employ insulin sensitizer as a therapeutic modality against NASH.